EFFICACY OF THE TSIOGKASPAETH GRID TEST IN EVALUATING VISUAL FIELD DEFECTS IN PATIENTS WITH GLAUCOMA
Published 2025 - 29th ESCRS Winter Meeting
Reference: PO040 | Type: Free Paper | DOI: 10.82333/3y7t-0b74
Authors: Anastasia Tsiogka* 1 , Klio Chatzistefanou 1 , Efthymios Karmiris 2 , Arianna De Rossi 3 , Evangelia Samoli 4 , Dimitrios Papaconstantinou 1 , George Spaeth 5
1Ophthalmology,Gennimatas Hospital,Athens,Greece, 2Ophthalmology,Hellenic Air Force General Hospital,Athens,Greece, 3Ophthalmology,Studi Santa Chiara,Verona,Italy, 4Hygiene, Epidemiology and Medical Statistics,National and Kapodistrian University,Athens,Greece, 5Ophthalmology,Wills Eye Hospital,Philadelphia,United States
Purpose
To determine the efficacy of an innovative low cost and portable test for visual field (VF) examination for identifying visual field defects in patients with glaucoma in everyday clinical practice
Setting
Cross sectional study
Methods
The TsiogkaSpaeth grid test was performed in each eye of all participants. Sensitivity, specificity, and positive and negative predictive values of the TSiogkaSpaeth grid scotoma area were assessed using the 24–2 Visual Field Humphrey Field Analyser as the reference standard. The Humphrey visual field examination and the TsiogkaSpaeth grid examination were performed the same day by two different examiners in order to avoid biases. The two field tests were evaluated by two experienced clinicians in order to confirm agreement.
Results
Sensitivity and specificity of the TsiogkaSpaeth grid test were 81.63% and 84.91% respectively. The Area Under Curve was 0.83 with 95% CI 0.76-0.91. There was a significant correlation between the TS grid test score and the Visual Field Index of the Humphrey Field Analyser 24-2 (r = 0.87, P < .0001) and the Mean Deviation of the Humphrey Field Analyser 24-2 (r = 0.85, P < .0001).
Conclusion
The sensitivity and specificity of the TS grid test were high in detecting visual field defects in glaucoma. The TsiogkaSpaeth grid test appears to be a reliable, low cost and easily accessed screening test in recording visual field defects in patients with glaucoma and it could be used in everyday clinical practice and in remote areas deprived of specialized health care services.